Trends of case detection and other indicators of leprosy in China during 1985-2002
- PMID: 16075742
Trends of case detection and other indicators of leprosy in China during 1985-2002
Abstract
Objective: To analyze the trends of case detection and other indicators of leprosy in China during 1985-2002.
Methods: Data reported by each province were collected by China National Leprosy Database in Nanjing P.R. China. All data about registered cases were put into computer for analysis.
Results: From 1985 to 2002, a total of 49,477 new leprosy cases had been detected. Among them, 69.5% were multibacillary cases and 25.4% had grade 2 disability. The child cases aged below 15 years accounted for 3.74% of total cases. Totally, 5824 cases and 303 cases relapsed after dapsone (DDS) mono-therapy and multidrug therapy (MDT), respectively. Case detection showed a marked reduction from 0.47/100,000 in 1985 to 0.18/100,000 in 1993 although there were several spurts due to operational factors. From 1994, case detection showed no significant decline. The grade 2 disability among new patients decreased from 31.4% in 1985 to 23.4% in 2002. The child case detection rate among new cases fluctuated between 2.70%-3.56% from 1999 to 2002. The incidence of relapse declined after the introduction of DDS mono-therapy. However, it increased after the introduction of MDT.
Conclusion: China experiences in leprosy control show that it will take a long time with continuing present leprosy control activities to bring down the case detection and other indicators to a very low level even after reaching the elimination goal of leprosy.
Similar articles
-
Fixed-duration multidrug therapy in multibacillary leprosy.Int J Lepr Other Mycobact Dis. 1997 Jun;65(2):230-7. Int J Lepr Other Mycobact Dis. 1997. PMID: 9251596
-
Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.Indian J Lepr. 2006 Apr-Jun;78(2):167-85. Indian J Lepr. 2006. PMID: 16927851
-
Progress and impact of multidrug therapy (MDT) implementation to leprosy control in Thailand.Nihon Rai Gakkai Zasshi. 1995 Nov;64(3):214-9. doi: 10.5025/hansen1977.64.214. Nihon Rai Gakkai Zasshi. 1995. PMID: 8582880
-
Leprosy in China.Nihon Hansenbyo Gakkai Zasshi. 2003 Aug;72(3):209-15. doi: 10.5025/hansen.72.209. Nihon Hansenbyo Gakkai Zasshi. 2003. PMID: 14598630 Review.
-
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):421-35. Int J Lepr Other Mycobact Dis. 1992. PMID: 1474281 Review.
Cited by
-
Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients.Emerg Microbes Infect. 2019;8(1):1479-1489. doi: 10.1080/22221751.2019.1677177. Emerg Microbes Infect. 2019. PMID: 31621517 Free PMC article.
-
Active surveillance of Hansen's Disease (leprosy): importance for case finding among extra-domiciliary contacts.PLoS Negl Trop Dis. 2013;7(3):e2093. doi: 10.1371/journal.pntd.0002093. Epub 2013 Mar 14. PLoS Negl Trop Dis. 2013. PMID: 23516645 Free PMC article.
-
Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic.Front Public Health. 2024 Jan 24;12:1148705. doi: 10.3389/fpubh.2024.1148705. eCollection 2024. Front Public Health. 2024. PMID: 38327578 Free PMC article.
-
Transmission of leprosy in Qiubei County, Yunnan, China: insights from an 8-year molecular epidemiology investigation.Infect Genet Evol. 2011 Mar;11(2):363-74. doi: 10.1016/j.meegid.2010.11.014. Epub 2010 Dec 1. Infect Genet Evol. 2011. PMID: 21129505 Free PMC article.
-
Molecular Surveillance of Antimicrobial Resistance of Mycobacterium leprae from Leprosy Patients in Zhejiang Province, China.Infect Drug Resist. 2022 Jul 27;15:4029-4036. doi: 10.2147/IDR.S368682. eCollection 2022. Infect Drug Resist. 2022. PMID: 35924023 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical